Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease

被引：54

作者：

Koseoglu, Emel ^{[1
]}

Karaman, Yahya

机构：

[1] Erciyes Univ, Fac Med, Dept Neurol, TR-38039 Kayseri, Turkey

[2] Gazi Univ, Fac Med, Dept Neurol, Ankara, Turkey

来源：

CLINICAL BIOCHEMISTRY | 2007年 / 40卷 / 12期

关键词：

Alzheimer disease; vascular dementia; homocysteine; folate; vitamin B12;

D O I：

10.1016/j.clinbiochem.2007.04.007

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: The aim of this study was to evaluate the relationship between homocysteine (Hey), folate and vitamin B 12 levels in vascular dementia (VaD) and Alzheimer Disease (AD) to elucidate if they had similar pathogenesis due to cerebrovascular injury. Design and methods: Plasma Hey and serum folate, vitamin B 12 levels were studied 67 VaD, 51 AD and 40 healthy control subjects. Vascular risk factors in these groups were also considered. Results: The changes in the levels of Hey, folate and vitamin B 12 were found to be not related with vascular risk factors. In Val), Hey level was higher (p < 0.001), folate and vitamin B12 levels were lower (p < 0.05 for folate, p < 0.001 for vitamin 1312) than those in AD. Hey level was negatively correlated with folate and vitamin B12 (p < 0.05) in VaD but in AD. Hcy/folate and Hcy/vitamin B12 ratios were the highest in Val). Conclusion: The increase of Hey in AD were seemed to be not related to cerebrovascular injury. It is possibly related to biochemical damages as result of oxidative stress. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：859 / 863

页数：5

共 26 条

[11] Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction [J].

Faraci, FM ;

Lentz, SR .

STROKE, 2004, 35 (02) :345-347

[12] Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction [J].

Hassan, A ;

Hunt, BJ ;

O'Sullivan, M ;

Bell, R ;

D'Souza, R ;

Jeffery, S ;

Bamford, JM ;

Markus, HS .

BRAIN, 2004, 127 :212-219

[13] The effect of folic acid fortification on plasma folate and total homocysteine concentrations [J].

Jacques, PF ;

Selhub, J ;

Bostom, AG ;

Wilson, PWF ;

Rosenberg, IH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1449-1454

[14] Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US Physicians [J].

Ma, J ;

Stampfer, MJ ;

Hennekens, CH ;

Frosst, P ;

Selhub, J ;

Horsford, J ;

Malinow, MR ;

Willett, WC ;

Rozen, R .

CIRCULATION, 1996, 94 (10) :2410-2416

[15] Plasma Homocysteine and Risk of Coexisting Silent Brain Infarction in Alzheimer's Disease [J].

Matsui, Toshifumi ;

Nemoto, Miyako ;

Maruyama, Masahiro ;

Yuzuriha, Takefumi ;

Yao, Hiroshi ;

Tanji, Haruko ;

Ootsuki, Mari ;

Tomita, Naoki ;

Matsushita, Sachio ;

Higuchi, Susumu ;

Yoshida, Yo-ichi ;

Seki, Takashi ;

Iwasaki, Koh ;

Furukawa, Katsutoshi ;

Arai, Hiroyuki .

NEURODEGENERATIVE DISEASES, 2005, 2 (06) :299-304

[16] Functional vitamin B12 deficiency and Alzheimer disease [J].

McCaddon, A ;

Regland, B ;

Hudson, P ;

Davies, G .

NEUROLOGY, 2002, 58 (09) :1395-1399

[17] Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland [J].

McIlroy, SP ;

Dynan, KB ;

Lawson, JT ;

Patterson, CC ;

Passmore, AP .

STROKE, 2002, 33 (10) :2351-2356

[18]

MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939

[19] Homocysteine, vitamin B6, and vascular disease in AD patients [J].

Miller, JW ;

Green, R ;

Mungas, DM ;

Reed, BR ;

Jagust, WJ .

NEUROLOGY, 2002, 58 (10) :1471-1475

[20] Homocysteine and Alzheimer's disease [J].

Morris, MS .

LANCET NEUROLOGY, 2003, 2 (07) :425-428

← 1 2 3 →